Dr. Reddy’s CDMO arm Aurigene inks long-term manufacturing pact with global pharma major
The initial portfolio comprises more than 20 products across sterile injectables, biologics and topical formulations, which will be manufactured at Aurigene’s facilities in India.
· 8/25/2026, 1:37:29 PM· 2 min read
The initial portfolio comprises more than 20 products across sterile injectables, biologics and topical formulations, which will be manufactured at Aurigene’s facilities in India.
Read original story →Related stories
business
Who does Iran trade with and what could Trump's 'economic D-Day' mean?
business
Air India seeks $1.5 billion from owners Tata, Singapore Air as losses mount, sources say
business
Natco Pharma invests $14mn in biotech firm eGenesis; total investment at $22mn
business